8 min. Read

18 digital health SPACs.

Issue 076

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote about how this newsletter will change starting next month (which is next week!). I also dug back into pricing strategies for DTx and shared a few thoughts on the rise of CGMs for wellness.

Earlier this week I sent out the first version of the new (free) funding newsletter, E&O

Sign-up for the newsletter for access.

It's a good one, too.

This article is for Exits & Outcomes subscribers only. Subscribe now to get the weekly newsletter. Enter your email below to subscribe today!

Newsletters

Flo Health’s 2025 revenue, expenses, losses and more.

7.31.26

4 min. Read

Samsung’s ACCESS Model partner. More ACCESS dropouts. Trials.

7.24.26

6 min. Read

CMS proposes to gut RPM/RTM. Thyme revenue. Swing Therapeutics acquired.

7.15.26

6 min. Read

Clinical trials snapshot: OpenEvidence, Hinge, Oura, North Shore Therapeutics, and more

7.10.26

9 min. Read

Hello Heart, Form Health pricing. Headway off the ACCESS Model list

6.26.26

3 min. Read

Oura subscription revs, rings sold, hardware margin. New ACCESS Model participants

6.05.26

7 min. Read

Six years of Oura’s financials: Revenue, profits, marketing spend and more

5.22.26

4 min. Read

ACCESS Model’s first dropout? Plus: A few new participants

5.08.26

6 min. Read

Are these Utah’s next four AI experiments? Plus: More on the Utah Pharmacy Board’s questions about Doctronic

4.17.26

9 min. Read

Emails show how Doctronic’s AI pilot blindsided Utah’s Medical Board

4.10.26

13 min. Read

18 digital health SPACs.

Welcome to E&O.

Sign-up for the newsletter for access.

E&O's weekly newsletter.